Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florence Joly

Showing results (251-260 of 336) with videos related to

Pageof 34
Sort By:
Cancer|August 16, 2021
Post-traumatic stress symptomatology and adjustment of medical oncology practice during the COVID-19 pandemic among adult patients with cancer in a day care hospitalFlorence Joly, Olivier Rigal, Lydia Guittet, et al.
JAMA Oncology|June 11, 2026
Avelumab Plus Methotrexate for Gestational Trophoblastic Tumors: The TROPHAMET Phase 1/2 Nonrandomized Clinical TrialBenoit You, Jean-Pierre Lotz, Pierre Descargues, et al.
British Journal of Cancer|April 1, 2022
Low probability of disease cure in advanced ovarian carcinomas before the PARP inhibitor eraBenoit You, Lilian Van Wagensveld, Michel Tod, et al.
JCO Precision Oncology|August 7, 2025
Activity of Platinum Monotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer and DNA Damage Repair Gene AlterationsMihaela Aldea, Emeline Orillard, Alice Bernard-Tessier, et al.
Nature Medicine|May 4, 2021
An adaptive, biomarker-directed platform study of durvalumab in combination with targeted therapies in advanced urothelial cancerThomas Powles, Danielle Carroll, Simon Chowdhury, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 18, 2025
Surgical approach and maintenance therapy in advanced low-grade serous ovarian cancer: Insights from the French ESME databaseThomas Papazyan, Elodie Martin, Patricia Pautier, et al.
Clinical Pharmacokinetics|July 4, 2024
Intra-individual Dose Escalation of Abiraterone According to Its Plasma Exposure in Patients with Progressive Metastatic Castration-Resistant Prostate Cancer: Results of the OPTIMABI TrialJérôme Alexandre, Stephane Oudard, Lisa Golmard, et al.
Journal of Gynecologic Oncology|July 7, 2026
Efficacy of secondary cytoreductive surgery for relapsed ovarian low-grade serous carcinoma: a multicenter analysis from French TMRG networkThomas Gaillard, Judicael Hotton, Enora Laas, et al.
European Journal of Cancer (Oxford, England : 1990)|November 6, 2021
Cabazitaxel activity in men with metastatic castration-resistant prostate cancer with and without DNA damage repair defectsMihaela Aldea, Laurent Lam, Emeline Orillard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2019
Safety and Efficacy of Nivolumab in Brain Metastases From Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II StudyRonan Flippot, Cécile Dalban, Brigitte Laguerre, et al.
Pageof 34

Showing results (251-260 of 336) with videos related to

Sort By:
Pageof 34
Cancer|August 16, 2021
Post-traumatic stress symptomatology and adjustment of medical oncology practice during the COVID-19 pandemic among adult patients with cancer in a day care hospitalFlorence Joly, Olivier Rigal, Lydia Guittet, et al.
JAMA Oncology|June 11, 2026
Avelumab Plus Methotrexate for Gestational Trophoblastic Tumors: The TROPHAMET Phase 1/2 Nonrandomized Clinical TrialBenoit You, Jean-Pierre Lotz, Pierre Descargues, et al.
British Journal of Cancer|April 1, 2022
Low probability of disease cure in advanced ovarian carcinomas before the PARP inhibitor eraBenoit You, Lilian Van Wagensveld, Michel Tod, et al.
JCO Precision Oncology|August 7, 2025
Activity of Platinum Monotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer and DNA Damage Repair Gene AlterationsMihaela Aldea, Emeline Orillard, Alice Bernard-Tessier, et al.
Nature Medicine|May 4, 2021
An adaptive, biomarker-directed platform study of durvalumab in combination with targeted therapies in advanced urothelial cancerThomas Powles, Danielle Carroll, Simon Chowdhury, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 18, 2025
Surgical approach and maintenance therapy in advanced low-grade serous ovarian cancer: Insights from the French ESME databaseThomas Papazyan, Elodie Martin, Patricia Pautier, et al.
Clinical Pharmacokinetics|July 4, 2024
Intra-individual Dose Escalation of Abiraterone According to Its Plasma Exposure in Patients with Progressive Metastatic Castration-Resistant Prostate Cancer: Results of the OPTIMABI TrialJérôme Alexandre, Stephane Oudard, Lisa Golmard, et al.
Journal of Gynecologic Oncology|July 7, 2026
Efficacy of secondary cytoreductive surgery for relapsed ovarian low-grade serous carcinoma: a multicenter analysis from French TMRG networkThomas Gaillard, Judicael Hotton, Enora Laas, et al.
European Journal of Cancer (Oxford, England : 1990)|November 6, 2021
Cabazitaxel activity in men with metastatic castration-resistant prostate cancer with and without DNA damage repair defectsMihaela Aldea, Laurent Lam, Emeline Orillard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2019
Safety and Efficacy of Nivolumab in Brain Metastases From Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II StudyRonan Flippot, Cécile Dalban, Brigitte Laguerre, et al.
Pageof 34